RADNOR, Pa.<\/span><\/span>, March 1, 2025<\/span><\/span> \/PRNewswire\/ — The law firm of Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0(www.ktmc.com<\/a>) \u00a0informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc.\u00a0(“TransMedics”) (NASDAQ: <\/a>TMDX<\/a>) on behalf of those who purchased or otherwise acquired TransMedics securities between February 28, 2023<\/span>, and January 10, 2025<\/span>, inclusive (the “Class Period”). The lead plaintiff deadline is April 15, 2025<\/span>.<\/b><\/p>\n CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: You can also contact attorney <\/b>Jonathan Naji, Esq.<\/span><\/a>\u00a0by calling (484) 270-1453 or by email at <\/b>[email\u00a0protected]<\/span><\/a>.\u00a0 <\/b><\/p>\n DEFENDANTS’ ALLEGED<\/span> MISCONDUCT: THE LEAD PLAINTIFF PROCESS: Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0encourages TransMedics investors who have suffered significant losses to contact the firm directly to acquire more information.<\/p>\n CLICK HERE<\/a>\u00a0TO SIGN UP FOR THE CASE<\/b>\u00a0OR GO TO: <\/b>https:\/\/www.ktmc.com\/new-cases\/transmedics-group-inc?utm_source=PR&utm_medium=link&utm_campaign=tmdx&mktm=r<\/a>\u00a0<\/p>\n ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:<\/u><\/b><\/p>\n Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0prosecutes class actions in state and federal courts throughout the country and around the world.\u00a0 The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud<\/span> and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud<\/span>, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0please visit www.ktmc.com<\/a>.<\/p>\n
<\/u><\/b>If you suffered TransMedics losses, <\/b>you may<\/b>\u00a0CLICK HERE<\/a>\u00a0or copy and paste the following link into your browser: <\/b>https:\/\/www.ktmc.com\/new-cases\/transmedics-group-inc?utm_source=PR&utm_medium=link&utm_campaign=tmdx&mktm=r<\/a>\u00a0<\/p>\n
<\/u><\/b>The complaint alleges<\/span> that, throughout the Class Period, Defendants made false and\/or misleading statements and\/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; and (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk.<\/p>\n
<\/u><\/b>TransMedics\u00a0investors may, no later than April 15, 2025<\/span>,<\/u><\/i><\/b> seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP<\/a>\u00a0or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.\u00a0 The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.<\/p>\n
![\"\"](\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC30241&Transmission_Id=202503012011PR_NEWS_USPR_____DC30241&DateId=20250301\")
<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"